Suppr超能文献

亚临床型功能性垂体腺瘤:沉默的肿瘤。

Subclinical hyperfunctioning pituitary adenomas: the silent tumors.

机构信息

Pituitary Center, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

出版信息

Best Pract Res Clin Endocrinol Metab. 2012 Aug;26(4):447-60. doi: 10.1016/j.beem.2012.01.002. Epub 2012 May 22.

Abstract

Pituitary adenomas are classified by function as defined by clinical symptoms and signs of hormone hypersecretion with subsequent confirmation on immunohistochemical staining. However, positive immunostaining for pituitary cell types has been shown for clinically nonfunctioning adenomas, and this entity is classified as silent functioning adenoma. Most common in these subtypes include silent gonadotroph adenomas, silent corticotroph adenomas and silent somatotroph adenomas. Less commonly, silent prolactinomas and thyrotrophinomas are encountered. Appropriate classification of these adenomas may affect follow-up care after surgical resection. Some silent adenomas such as silent corticotroph adenomas follow a more aggressive course, necessitating closer surveillance. Furthermore, knowledge of the immunostaining characteristics of silent adenomas may determine postoperative medical therapy. This article reviews the incidence, clinical behavior, and pathologic features of clinically silent pituitary adenomas.

摘要

垂体腺瘤根据功能分类,由激素分泌过多的临床症状和体征定义,并随后通过免疫组织化学染色确认。然而,已经证明临床上无功能的腺瘤存在垂体细胞类型的阳性免疫染色,这种肿瘤被归类为无功能性腺瘤。这些亚型中最常见的包括无功能促性腺腺瘤、无功能促肾上腺皮质激素腺瘤和无功能生长激素腺瘤。不太常见的是,无功能泌乳素腺瘤和促甲状腺素腺瘤也会遇到。对这些腺瘤进行适当的分类可能会影响手术后的随访护理。一些无功能性腺瘤,如无功能促肾上腺皮质激素腺瘤,具有更具侵袭性的病程,需要更密切的监测。此外,对无功能性腺瘤的免疫染色特征的了解可能会决定术后的药物治疗。本文回顾了临床上无功能性垂体腺瘤的发病率、临床行为和病理特征。

相似文献

1
Subclinical hyperfunctioning pituitary adenomas: the silent tumors.亚临床型功能性垂体腺瘤:沉默的肿瘤。
Best Pract Res Clin Endocrinol Metab. 2012 Aug;26(4):447-60. doi: 10.1016/j.beem.2012.01.002. Epub 2012 May 22.
3
Nonfunctioning Pituitary Lesions.无功能垂体病变。
Otolaryngol Clin North Am. 2022 Apr;55(2):343-350. doi: 10.1016/j.otc.2021.12.015.
4
Rab3B immunoexpression in human pituitary adenomas.Rab3B在人垂体腺瘤中的免疫表达。
Appl Immunohistochem Mol Morphol. 2009 May;17(3):185-8. doi: 10.1097/PAI.0b013e31818fa0ed.
6
Gonadotroph adenoma with secondary hypersecretion of testosterone.促性腺激素腺瘤伴睾丸酮的继发性分泌过多。
World Neurosurg. 2013 Dec;80(6):900.e7-11. doi: 10.1016/j.wneu.2012.11.069. Epub 2012 Nov 28.

引用本文的文献

3
Elevated risk of recurrence and retreatment for silent pituitary adenomas.垂体腺瘤患者复发和再治疗风险增加。
Pituitary. 2024 Apr;27(2):204-212. doi: 10.1007/s11102-024-01382-3. Epub 2024 Feb 12.
4
Aggressive nonfunctioning pituitary neuroendocrine tumors.侵袭性无功能性垂体神经内分泌肿瘤。
Brain Tumor Pathol. 2022 Oct;39(4):183-199. doi: 10.1007/s10014-022-00441-6. Epub 2022 Jun 20.
7
Metastatic Colon Cancer in the Pituitary: A Case Report with Review of Literature.垂体转移性结肠癌:一例报告并文献复习
Asian J Neurosurg. 2021 Dec 18;16(4):872-875. doi: 10.4103/ajns.AJNS_52_21. eCollection 2021 Oct-Dec.
8
Plurihormonal pituitary macroadenoma:  a case report.多激素垂体大腺瘤:一例报告。
J Med Case Rep. 2021 Jul 29;15(1):407. doi: 10.1186/s13256-021-02948-6.

本文引用的文献

1
Clinically silent somatotroph adenomas are common.临床上无功能的生长激素腺瘤很常见。
Eur J Endocrinol. 2011 Jul;165(1):39-44. doi: 10.1530/EJE-11-0216. Epub 2011 Apr 14.
4
Pathogenesis of pituitary tumors.垂体肿瘤的发病机制。
Nat Rev Endocrinol. 2011 May;7(5):257-66. doi: 10.1038/nrendo.2011.40. Epub 2011 Mar 22.
8
Non-functioning pituitary adenomas.无功能垂体腺瘤。
Best Pract Res Clin Endocrinol Metab. 2009 Oct;23(5):625-38. doi: 10.1016/j.beem.2009.05.005.
9
Acromegaly pathogenesis and treatment.肢端肥大症的发病机制与治疗
J Clin Invest. 2009 Nov;119(11):3189-202. doi: 10.1172/JCI39375. Epub 2009 Nov 2.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验